New Delhi: Drug major Sun Pharma arm Taro Pharmaceuticals USA Inc is recalling 17,100 kits of Kamedis Bio-Herbal Dandruff Care System in the US on account of being sub-potent drug.
"Taro Pharmaceuticals USA Inc is recalling the drug because of it being subpotent drug: out of specification assay values on stability for the active ingredient, zinc pyrithione," the latest Enforcement Report of health regulator USFDA has said.
The therapeutic 2-step Kamedis Bio-Herbal Dandruff Care System is used for treating itching and flaking associated with dandruff and seborrheic dermatitis.
The voluntary nationwide ongoing recall is a class III recall, US Food and Drug Administration (USFDA) said.
According to USFDA, a class III recall is initiated in "a situation in which use of or exposure to a violative product is not likely to cause adverse health onsequences".
Firstpost is now on WhatsApp. For the latest analysis, commentary and news updates, sign up for our WhatsApp services. Just go to Firstpost.com/Whatsapp and hit the Subscribe button.
Updated Date: Nov 16, 2016 18:31:20 IST